Financhill
Sell
36

DCTH Quote, Financials, Valuation and Earnings

Last price:
$9.51
Seasonality move :
-8.83%
Day range:
$9.31 - $9.55
52-week range:
$8.12 - $18.23
Dividend yield:
0%
P/E ratio:
1,089.66x
P/S ratio:
4.52x
P/B ratio:
2.86x
Volume:
239.6K
Avg. volume:
488K
1-year change:
-39.42%
Market cap:
$329M
Revenue:
$37.2M
EPS (TTM):
$0.01

Analysts' Opinion

  • Consensus Rating
    Delcath Systems, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 5 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $22.33, Delcath Systems, Inc. has an estimated upside of 135.58% from its current price of $9.53.
  • Price Target Downside
    According to analysts, the lowest downside price target is $18.00 representing -89.87% downside risk from its current price of $9.53.

Fair Value

  • According to the consensus of 5 analysts, Delcath Systems, Inc. has 135.58% upside to fair value with a price target of $22.33 per share.

DCTH vs. S&P 500

  • Over the past 5 trading days, Delcath Systems, Inc. has underperformed the S&P 500 by -6.75% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Delcath Systems, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Delcath Systems, Inc. has grown year-over-year revenues for 7 quarters straight. In the most recent quarter Delcath Systems, Inc. reported revenues of $20.6M.

Earnings Growth

  • Delcath Systems, Inc. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Delcath Systems, Inc. reported earnings per share of $0.02.
Enterprise value:
241M
EV / Invested capital:
--
Price / LTM sales:
4.52x
EV / EBIT:
40.97x
EV / Revenue:
3.03x
PEG ratio (5yr expected):
--
EV / Free cash flow:
20.02x
Price / Operating cash flow:
29.90x
Enterprise value / EBITDA:
38.92x
Gross Profit (TTM):
$68.7M
Return On Assets:
1.37%
Net Income Margin (TTM):
1.51%
Return On Equity:
1.59%
Return On Invested Capital:
1.56%
Operating Margin:
-1.89%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $2.2M $22.6M $79.6M $11.2M $20.6M
Gross Profit $977K $18.4M $68.7M $9.6M $17.9M
Operating Income -$34.7M -$26.8M $5.9M -$1.3M -$388K
EBITDA -$34.2M -$26.5M $6.2M -$1.1M -$296K
Diluted EPS -$3.35 -$1.36 $0.01 $0.06 $0.02
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $32.3M $18.5M $46.1M $28.9M $120.6M
Total Assets $34.4M $20.2M $47.6M $31.7M $124.3M
Current Liabilities $5.4M $14.4M $14M $21.6M $8M
Total Liabilities $22.7M $25.5M $22.9M $23.1M $9.4M
Total Equity $11.7M -$5.2M $24.7M $8.6M $114.8M
Total Debt $16.2M $11M $6M $3M $855K
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations -$30.4M -$25.9M $13.3M -$3.6M $4.8M
Cash From Investing -$39K -$5.4M -$41.3M -$697K -$466K
Cash From Financing $57M -$974K $61.4M -$2.1M $3.1M
Free Cash Flow -$30.5M -$26.2M $12M -$3.9M $4.3M
DCTH
Sector
Market Cap
$329M
$25.8M
Price % of 52-Week High
52%
48.88%
Dividend Yield
0%
0%
Shareholder Yield
-16.45%
-1.67%
1-Year Price Total Return
-42.09%
-21.92%
Beta (5-Year)
0.373
0.499
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $9.55
200-day SMA
Sell
Level $11.41
Bollinger Bands (100)
Sell
Level 0 - 0
Chaikin Money Flow
Sell
Level --
20-day SMA
Sell
Level $9.82
Relative Strength Index (RSI14)
Sell
Level 45.77
ADX Line
Neutral
Level 0
Williams %R
Neutral
Level -58.5714
50-day SMA
Sell
Level $10.03
MACD (12, 26)
Buy
Level 2.19
25-day Aroon Oscillator
Sell
Level -40
On Balance Volume
Neutral
Level --

Financial Scores

Buy
Altman Z-Score (Annual)
Level (21.7458)
Buy
CA Score (Annual)
Level (-0.11)
--
Beneish M-Score (Annual)
Level (--)
Buy
Momentum Score
Level (3)
Sell
Ohlson Score
Level (5.6639)
Buy
Piotroski F Score (Annual)
Level (7)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (4)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded on August 5, 1988 and is headquartered in Queensbury, NY.

Stock Forecast FAQ

In the current month, DCTH has received 5 Buy ratings 0 Hold ratings, and 0 Sell ratings. The DCTH average analyst price target in the past 3 months is $22.33.

  • Where Will Delcath Systems, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Delcath Systems, Inc. share price will rise to $22.33 per share over the next 12 months.

  • What Do Analysts Say About Delcath Systems, Inc.?

    Analysts are divided on their view about Delcath Systems, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Delcath Systems, Inc. is a Sell and believe this share price will drop from its current level to $18.00.

  • What Is Delcath Systems, Inc.'s Price Target?

    The price target for Delcath Systems, Inc. over the next 1-year time period is forecast to be $22.33 according to 5 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is DCTH A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Delcath Systems, Inc. is a Buy. 5 of 5 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of DCTH?

    You can purchase shares of Delcath Systems, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Delcath Systems, Inc. shares.

  • What Is The Delcath Systems, Inc. Share Price Today?

    Delcath Systems, Inc. was last trading at $9.51 per share. This represents the most recent stock quote for Delcath Systems, Inc.. Yesterday, Delcath Systems, Inc. closed at $9.53 per share.

  • How To Buy Delcath Systems, Inc. Stock Online?

    In order to purchase Delcath Systems, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Buy
56
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Sell
49
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 35x

Sell
46
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 28x

Alerts

Buy
73
HYMC alert for Feb 19

Hycroft Mining Holding Corp. [HYMC] is up 3.81% over the past day.

Buy
57
GLBE alert for Feb 20

Global-e Online Ltd. [GLBE] is up 4.19% over the past day.

Sell
37
ACLS alert for Feb 20

Axcelis Technologies, Inc. [ACLS] is down 1.71% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock